Large-scale testing (Phase 3)Study completedNCT02091986
What this trial is testing
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
Who this might be right for
Asthma
AstraZeneca 882